Radiology Personnel
Delphine Chen, M.D.
Professor
Wil B. Nelp, M.D. Endowed Professorship in Nuclear Medicine
Director of Molecular Imaging, Fred Hutchinson Cancer Center
Nuclear Medicine
Biography
Delphine L. Chen, MD, is a board-certified nuclear medicine physician with broad expertise in PET and nuclear medicine molecular imaging diagnostic tests and specific clinical interests in cancer imaging and therapy. She believes that molecular imaging can provide unique information about cancer behavior that can affect treatment decisions. She is also committed to working with integrated collaborative multidisciplinary teams to provide the best possible imaging care for her patients.
Recent Publications (via Semantic Scholar)
Abstract 928: Glypican-3 targeted thorium-227 alpha therapy reduces tumor burden in an orthotopic xenograft model of hepatocellular carcinomaK. Labadie, D. Hamlin, Aimee L. Kenoyer, et al. - Published 2021 - EXPERIMENTAL AND MOLECULAR THERAPEUTICS
Use of 18F-fluciclovine PET/CT (FluPET) for prostate cancer (PC): Initial results from a prospective registry at a tertiary academic center.
R. Wong, Heather H Cheng, S. Holt, et al. - Published 2021
How Accurately does PSMA Inhibitor 18F-DCFPyL-PET-CT Image Prostate Cancer?
L. True, Delphine L. Chen - Published 2021 - CLINICAL CANCER RESEARCH
Selective Imaging of Lung Macrophages Using [11C]PBR28-Based Positron Emission Tomography
Delphine L. Chen, E. Agapov, Kangyun Wu, et al. - Published 2021 - MOLECULAR IMAGING AND BIOLOGY
Abstract PD6-10: 18F-fluoroestradiol (fes) and 18f-fluorodeoxyglucose (fdg) pet imaging in metastatic lobular breast cancer
Poorni M. Manohar, L. Peterson, V. Wu, et al. - Published 2021
Selective Imaging of Lung Macrophages Using [11C]PBR28-Based Positron Emission Tomography
Delphine L. Chen, E. Agapov, Kangyun Wu, et al. - Published 2021 - MOLECULAR IMAGING AND BIOLOGY
Glypican-3 targeted delivery of 89Zr and 90Y as a theranostic radionuclide platform for hepatocellular carcinoma
K. Labadie, A. Ludwig, A. Lehnert, et al. - Published 2021 - SCIENTIFIC REPORTS
The fluciclovine (FACBC) PET/CT site-directed therapy of oligometastatic prostate cancer (Flu-BLAST-PC) trial.
R. Wong, S. Holt, Jing Zeng, et al. - Published 2021
Consensus Recommendations on the Use of 18F-FDG PET/CT in Lung Disease
Delphine L. Chen, Safia Ballout, L. Chen, et al. - Published 2020 - THE JOURNAL OF NUCLEAR MEDICINE
Radiologic Assessment of Groin Lymph Nodes in Pelvic Malignancies
S. Rudra, Dominique Fuser, T. DeWees, et al. - Published 2020 - INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER